Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial.
about
A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury.Is the Prophylactic Use of Hepatoprotectants Necessary in Anti-Tuberculosis Treatment?Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysisCytochrome P450 1A1 and 1B1 promoter CpG island methylation regulates rat liver injury induced by isoniazid.
P2860
Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Preventive use of a hepatoprot ...... A randomized controlled trial.
@en
type
label
Preventive use of a hepatoprot ...... A randomized controlled trial.
@en
prefLabel
Preventive use of a hepatoprot ...... A randomized controlled trial.
@en
P2093
P2860
P356
P1476
Preventive use of a hepatoprot ...... A randomized controlled trial.
@en
P2093
Guisheng Xu
Hongqiu Pan
Jianming Wang
Simin Zhang
Xianzhen Peng
Xianzhi Zheng
P2860
P304
P356
10.1111/JGH.13070
P577
2015-08-04T00:00:00Z